Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

34.62
Delayed Data
As of Oct 20
 -0.09 / -0.26%
Today’s Change
25.55
Today|||52-Week Range
35.60
+26.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line3.3B1.2B3.1B3.5B
 
 
 
 
 
Depreciation2.7B3.1B2.7B2.3B
 
 
 
 
 
Total Other Cash Flow1.4B282.8M-2.2B-2.5B
 
 
 
 
 
Funds From Operations7.3B4.7B3.5B3.3B
 
 
 
 
 
Funds From/For Other Operating Expenses-165.5M-2.5B48.9M-919.6M
 
 
 
 
 
Net Cash Flow - Operating Activities7.5B7.2B3.4B4.3B
 
 
 
 
 
 
InvestingIncrease In Investments-90.7M-199.2M-101.8M-434.0M
 
 
 
 
 
Decrease In Investments167.5M92.6M375.3M3.0M
 
 
 
 
 
Capital Expenditures-739.8M-1.0B-1.3B-1.4B
 
 
 
 
 
Fixed Asset Disposal110.7M157.4M46.9M81.4M
 
 
 
 
 
Net Assets From Acquisitions -1.2B-4.5B-3.0B-2.9B
 
 
 
 
 
Other Investing - Sources34.9M0.001.1B1.4B
 
 
 
 
Net Cash Flow Investing-3.0B-7.1B-4.4B-4.1B
 
 
 
 
 
 
FinancingShort Term Borrowings-5.0M517.9M-628.8M-395.3M
 
 
 
 
 
Long Term Borrowings0.00915.3M5.9B2.5B
 
 
 
 
Long Term Debt Reduction-26.9M-782.8M-924.3M-15.9M
 
 
 
 
 
Net Proceeds Stock Sale480.6M277.9M42.9M46.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends-3.5B-3.5B-3.5B-3.5B
 
 
 
 
 
Cash Dividends Paid - Total-3.5B-3.5B-3.5B-3.5B
 
 
 
 
 
Other Sources - Financing0.000.000.0017.9M
 
 
Other Uses - Financing35.9M115.5M0.000.00
 
 
 
Net Cash Flow - Financing-3.0B-2.7B876.4M-1.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-64.8M-151.4M-75.9M20.9M
 
 
 
 
 
 
Net Change In Cash1.5B-2.7B-36.9M-1.2B